Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Chordoma
NCT00150072Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of imatinib in chordoma, sponsored by Novartis. Started Oct 2004; status: completed.
02
Drugs
03
Conditions
chordoma
Beyond the preview
Go deeper on NCT00150072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150072.